eLaws | eCases | United States Code | Federal Courts |
 Code of Federal Regulations (Last Updated: November 8, 2024)
 Title 21 - Food and Drugs
 Chapter I - Food and Drug Administration, Department of Health and Human Services
 SubChapter E - Animal Drugs, Feeds, and Related Products
 Part 516 - New Animal Drugs for Minor Use and Minor Species
 Subpart E - Conditionally Approved New Animal Drugs For Minor Use and Minor Species

  § 516.1684 - Paclitaxel.  

Latest version.

  • § 516.1684 Paclitaxel.

    (a) Specifications. Each vial of powder contains 60 milligrams (mg) paclitaxel. Each milliliter of constituted solution contains 1 mg paclitaxel.

    (b) Sponsor. See No. 052818 in 510.600(c) of this chapter.

    (c) Conditions of use in dogs —

    (1) Amount. Administer 150 mg per square meter of body surface area intravenously over 15 to 30 minutes, once every 3 weeks, for up to 4 doses.

    (2) Indications for use. For the treatment of nonresectable stage III, IV, or V mammary carcinoma in dogs that have not received previous chemotherapy or radiotherapy. For the treatment of resectable and nonresectable squamous cell carcinoma in dogs that have not received previous chemotherapy or radiotherapy.

    (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling.

    [79 FR 18158, Apr. 1, 2014]